MATERIAL EVENT4536.TTSE

Santen Pharmaceutical: change in major shareholder

Summary

SANTEN PHARMACEUTICAL CO., LTD. filed an extraordinary report via EDINET on 2026-10-27 10:41 JST. Reason(s) cited: extraordinary report.

Open the price chart on TradingView.

Source: EDINET S100ZA45 ↗ · PDL1.0 · Not investment advice